EA201491010A1 - Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина - Google Patents

Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина

Info

Publication number
EA201491010A1
EA201491010A1 EA201491010A EA201491010A EA201491010A1 EA 201491010 A1 EA201491010 A1 EA 201491010A1 EA 201491010 A EA201491010 A EA 201491010A EA 201491010 A EA201491010 A EA 201491010A EA 201491010 A1 EA201491010 A1 EA 201491010A1
Authority
EA
Eurasian Patent Office
Prior art keywords
osteopontin
prevention
optimates
options
suppressing
Prior art date
Application number
EA201491010A
Other languages
English (en)
Russian (ru)
Inventor
Сюзан Р. Риттлинг
Петер Лангборг Вейсе
Анья Серена
Original Assignee
Арла Фудз Амба
ФОРСАЙТ ДЕНТАЛ ИНФЁМЭРИ ФО ЧИЛДРЕН (д.б.э. ДЕ ФОРСАЙТ ИНСТИТЬЮТ)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арла Фудз Амба, ФОРСАЙТ ДЕНТАЛ ИНФЁМЭРИ ФО ЧИЛДРЕН (д.б.э. ДЕ ФОРСАЙТ ИНСТИТЬЮТ) filed Critical Арла Фудз Амба
Publication of EA201491010A1 publication Critical patent/EA201491010A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EA201491010A 2011-12-07 2012-12-07 Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина EA201491010A1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567899P 2011-12-07 2011-12-07
US201261673912P 2012-07-20 2012-07-20
EP12177329 2012-07-20
PCT/US2012/068628 WO2013086459A1 (en) 2011-12-07 2012-12-07 Osteopontin variants for use in suppression or prevention of tumor growth and compositions containing such osteopontin variants

Publications (1)

Publication Number Publication Date
EA201491010A1 true EA201491010A1 (ru) 2015-01-30

Family

ID=48574961

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201491010A EA201491010A1 (ru) 2011-12-07 2012-12-07 Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина

Country Status (12)

Country Link
US (1) US20150344534A1 (enExample)
EP (1) EP2788015A1 (enExample)
JP (1) JP2015500836A (enExample)
KR (1) KR20140104474A (enExample)
CN (1) CN104080472A (enExample)
AR (1) AR089136A1 (enExample)
AU (1) AU2012347468A1 (enExample)
BR (1) BR112014013565A2 (enExample)
CA (1) CA2858379A1 (enExample)
EA (1) EA201491010A1 (enExample)
WO (1) WO2013086459A1 (enExample)
ZA (1) ZA201404920B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015001092A1 (en) * 2013-07-05 2015-01-08 Arla Foods Amba Mammalian milk osteopontin for enhancing immune responsiveness
EP4326758A4 (en) * 2021-04-20 2025-03-19 University of Cincinnati A vaccine adjuvant for infectious diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888552A (en) * 1988-04-29 1999-03-30 Immunotec Research Corporation Ltd. Anti-cancer therapeutic compositions containing whey protein concentrate
IL106576A (en) * 1992-08-13 2000-08-13 Immunotec Res Corp Ltd Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer
MXPA01010332A (es) * 1999-04-15 2002-09-18 Childrens Medical Center Metodos y composiciones para modular una respuesta inmunitaria.
PT1244702E (pt) * 2000-01-07 2006-08-31 Arla Foods Amba Processo para o isolamento da osteopontina do leite
NZ507335A (en) * 2000-10-05 2004-10-29 New Zealand Dairy Board Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP
NZ546398A (en) * 2003-09-18 2009-03-31 Arla Foods Amba Infant formula
SM200600031B (it) * 2006-10-06 2009-05-11 Gianluca Mech Integratore alimentare con attivatore proteico
WO2009052286A1 (en) * 2007-10-16 2009-04-23 Ventana Medical Systems, Inc. Grading, staging, and prognosing cancer using osteopontin-c

Also Published As

Publication number Publication date
JP2015500836A (ja) 2015-01-08
US20150344534A1 (en) 2015-12-03
AU2012347468A1 (en) 2014-06-26
BR112014013565A2 (pt) 2019-09-24
AR089136A1 (es) 2014-07-30
CN104080472A (zh) 2014-10-01
WO2013086459A1 (en) 2013-06-13
KR20140104474A (ko) 2014-08-28
EP2788015A1 (en) 2014-10-15
CA2858379A1 (en) 2013-06-13
ZA201404920B (en) 2015-12-23

Similar Documents

Publication Publication Date Title
ZA202308496B (en) Pharmaceutical compositions of therapeutically active compounds
UA111386C2 (uk) Піридопіразини, які мають протиракову активність через інгібування fgfr-кіназ
NZ743274A (en) Substituted tricyclic compounds as fgfr inhibitors
MX376008B (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
EA201391507A1 (ru) АНТИТЕЛА ПРОТИВ c-Kit И ИХ ПРИМЕНЕНИЕ
UA110943C2 (uk) N-ацилсульфонамідні промотори апоптозу
EA201592068A1 (ru) Ингибиторы энхансера zeste гомолога 2
MX371108B (es) Pirimidopirimidinonas utiles como iniciadores de wee-1 cinasa.
IN2012MN02591A (enExample)
IN2014MN02049A (enExample)
IN2014MN00986A (enExample)
EA201391644A1 (ru) Частично насыщенные трициклические соединения и способы их получения и применения
EA201301240A1 (ru) Полиморфная форма бензоата линаглиптина
PH12016501788B1 (en) Pharmaceutical compositions of therapeutically active compounds
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
EA201592003A1 (ru) Микропищевые добавки для иммунитета
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2015017539A (es) Composiciones nanoparticuladas y formulaciones de compuestos de piperazina.
IN2014DN03010A (enExample)
MX2016004094A (es) Composicion farmaceutica que comprende capecitabina y ciclofosfamida.
EA201491010A1 (ru) Варианты остеопонтина для применения в подавлении или предупреждении опухолевого роста и композиции, содержащие такие варианты остеопонтина
EA202091164A1 (ru) Производные кофейной кислоты и их применение
ZA201606135B (en) Pharmaceutical compositions of therapeutically active compounds
MX2011003390A (es) Compuestos y composiciones útiles en el tratamiento de enfermedades cardiacas con efectos secundarios reducidos.